Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 2
2006 2
2007 5
2008 8
2009 5
2010 8
2011 6
2012 5
2013 10
2014 14
2015 20
2016 15
2017 19
2018 10
2019 4
2020 14
2021 18
2022 16
2023 12
2024 17
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, Bae SC, Brohawn PZ, Pineda L, Berglind A, Tummala R; TULIP-2 Trial Investigators. Morand EF, et al. N Engl J Med. 2020 Jan 16;382(3):211-221. doi: 10.1056/NEJMoa1912196. Epub 2019 Dec 18. N Engl J Med. 2020. PMID: 31851795 Clinical Trial.
Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial.
Jourde-Chiche N, Costedoat-Chalumeau N, Baumstarck K, Loundou A, Bouillet L, Burtey S, Caudwell V, Chiche L, Couzi L, Daniel L, Deligny C, Dussol B, Faguer S, Gobert P, Gondran G, Huart A, Hummel A, Kalbacher E, Karras A, Lambert M, Le Guern V, Lebourg L, Loubière S, Maillard-Lefebvre H, Maurier F, Pha M, Queyrel V, Remy P, Sarrot-Reynauld F, Verhelst D, Hachulla E, Amoura Z, Daugas E; WIN-Lupus study group. Jourde-Chiche N, et al. Among authors: le guern v. Ann Rheum Dis. 2022 Oct;81(10):1420-1427. doi: 10.1136/annrheumdis-2022-222435. Epub 2022 Jun 20. Ann Rheum Dis. 2022. PMID: 35725295 Free PMC article. Clinical Trial.
Therapies for systemic lupus erythematosus.
de Frémont GM, Lenfant T, Le Guern V, Costedoat-Chalumeau N. de Frémont GM, et al. Among authors: le guern v. Lancet. 2024 Nov 30;404(10468):2163. doi: 10.1016/S0140-6736(24)02380-8. Lancet. 2024. PMID: 39615996 No abstract available.
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study.
Fisher BA, Mariette X, Papas A, Grader-Beck T, Bootsma H, Ng WF, van Daele PLA, Finzel S, Noaiseh G, Elgueta S, Hermann J, McCoy SS, Akpek E, Bookman A, Sopala M, Montecchi-Palmer M, Luo WL, Scheurer C, Hueber W; TWINSS study group. Fisher BA, et al. Lancet. 2024 Aug 10;404(10452):540-553. doi: 10.1016/S0140-6736(24)01211-X. Epub 2024 Jul 31. Lancet. 2024. PMID: 39096929 Clinical Trial.
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort.
Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, Maurier F, Jouneau S, Bienvenu B, Puéchal X, Aumaître O, Le Guenno G, Le Quellec A, Cevallos R, Fain O, Godeau B, Seror R, Dunogué B, Mahr A, Guilpain P, Cohen P, Aouba A, Mouthon L, Guillevin L; French Vasculitis Study Group. Comarmond C, et al. Arthritis Rheum. 2013 Jan;65(1):270-81. doi: 10.1002/art.37721. Arthritis Rheum. 2013. PMID: 23044708
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts.
Nguyen Y, Nocturne G, Henry J, Ng WF, Belkhir R, Desmoulins F, Bergé E, Morel J, Perdriger A, Dernis E, Devauchelle-Pensec V, Sène D, Dieudé P, Couderc M, Fauchais AL, Larroche C, Vittecoq O, Salliot C, Hachulla E, Le Guern V, Gottenberg JE, Mariette X, Seror R. Nguyen Y, et al. Among authors: le guern v. Lancet Rheumatol. 2024 Apr;6(4):e216-e225. doi: 10.1016/S2665-9913(23)00340-5. Epub 2024 Mar 1. Lancet Rheumatol. 2024. PMID: 38437852 Free PMC article.
Issues with pregnancy in systemic lupus.
Le Guern V, Guettrot-Imbert G, Dupré A, Perol S, Pannier E, Morel N, Costedoat-Chalumeau N. Le Guern V, et al. Joint Bone Spine. 2024 Dec;91(6):105713. doi: 10.1016/j.jbspin.2024.105713. Epub 2024 Mar 4. Joint Bone Spine. 2024. PMID: 38447695 Free article. Review.
Conception in women with primary Sjögren's disease.
Martin de Frémont G, Le Guern V, Seror R. Martin de Frémont G, et al. Among authors: le guern v. RMD Open. 2024 Oct 2;10(4):e004927. doi: 10.1136/rmdopen-2024-004927. RMD Open. 2024. PMID: 39357928 Free PMC article. No abstract available.
[The pre-pregnancy counseling].
Le Guern V, Guettrot-Imbert G, Costedoat-Chalumeau N. Le Guern V, et al. Rev Med Interne. 2015 Mar;36(3):151-3. doi: 10.1016/j.revmed.2014.07.012. Epub 2014 Dec 22. Rev Med Interne. 2015. PMID: 25541231 French.
Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study.
Rocca J, Beydon M, Le Guern V, Hachulla E, Couderc M, Jousse-Joulin S, Devauchelle-Pensec V, Gottenberg JE, Vittecoq O, Lavigne C, Schmidt J, Larroche C, Mariette X, Seror R, Nocturne G. Rocca J, et al. Among authors: le guern v. Lancet Rheumatol. 2024 Oct;6(10):e703-e712. doi: 10.1016/S2665-9913(24)00198-X. Epub 2024 Aug 22. Lancet Rheumatol. 2024. PMID: 39182508
188 results